Infection of Aortic Endograft Caused by Coccidioidomycosis

Am J Med. 2020 Jan;133(1):e1-e2. doi: 10.1016/j.amjmed.2019.07.013. Epub 2019 Jul 25.

Authors

James Bardwell¹, Jessica August², Sumaya Farran², Catalin Florita², Fariba Donovan³, Tirdad T Zangeneh³

Affiliations

¹ Department of Internal Medicine at South Campus, College of Medicine, University of Arizona, Tucson. Electronic address: james.bardwell@bannerhealth.com.
² College of Medicine, Division of Infectious Diseases, University of Arizona, Tucson.
³ College of Medicine, Division of Infectious Diseases, University of Arizona, Tucson; College of Medicine, Valley Fever Center for Excellence, University of Arizona, Tucson.

PMID: 31351044
DOI: 10.1016/j.amjmed.2019.07.013

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Amphotericin B / therapeutic use
Anti-Bacterial Agents / therapeutic use
Antifungal Agents / therapeutic use
Aortic Aneurysm, Abdominal / surgery
Aortitis / diagnosis*
Aortitis / therapy
Blood Vessel Prosthesis Implantation
Blood Vessel Prosthesis*
Clostridium Infections / drug therapy
Coccidioidomycosis / diagnosis*
Coccidioidomycosis / therapy
Device Removal
Enterobacter cloacae
Enterobacteriaceae Infections / drug therapy
Fluconazole / therapeutic use
Humans
Magnetic Resonance Angiography
Male
Pneumonia, Bacterial / drug therapy
Postoperative Complications / drug therapy
Prosthesis-Related Infections / diagnosis*
Prosthesis-Related Infections / therapy

Substances

Anti-Bacterial Agents
Antifungal Agents
liposomal amphotericin B
Amphotericin B
Fluconazole